PRQR ProQR Therapeutics N.V.: institutional ownership and insider trading
71 funds reported holding $113M of ProQR Therapeutics N.V. in their latest 13F filings; in Q2 2026 funds net bought $47.7M, with 12 new positions and 11 funds selling out; over the last 12 months insiders bought $1.34M and sold $0 on the open market.
Famous investors holding PRQR
- Ken Griffin (Citadel Advisors): $2.20M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $2.12M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $299K, 0.0% of the portfolio
Largest institutional holders of PRQR
- ADAGE CAPITAL PARTNERS GP, L.L.C. — $16.8M
- Aberdeen Group plc — $16.6M
- Affinity Asset Advisors, LLC — $10.3M
- Privium Fund Management B.V. — $10.3M
- Ikarian Capital, LLC — $6.37M
- Woodline Partners LP — $6.10M
- HEIGHTS CAPITAL MANAGEMENT, INC — $5.14M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $3.29M
- SPHERA FUNDS MANAGEMENT LTD. — $3.27M
- Kynam Capital Management, LP — $2.91M
Recent PRQR insider trades
- Jul 31, 2026: de Boer Daniel Anton bought 200,000 shares ($354K)
- Jul 17, 2026: Filius Bart bought 150,000 shares ($258K)
- Jul 9, 2026: de Boer Daniel Anton bought 150,000 shares ($261K)
- Jul 7, 2026: de Boer Daniel Anton bought 150,000 shares ($239K)
5%+ owners
- ELI LILLY & Co: 15.6% (Schedule 13G/A, filed Jul 24, 2026)
- Van Herk Investments B.V.: 10.9% (Schedule 13D/A, filed Jul 29, 2026)
- Aberdeen Group plc: 6.3% (Schedule 13G, filed Jul 29, 2026)
- PATRICK JOHAN HENDRIK KROL: 5.2% (Schedule 13G/A, filed Jul 15, 2026)